1. Society of surgical oncology 57th Annual Cancer Symposium

   Events Pages: S47 - S48

2. The novel hepatitis C virus (HCV) alternate reading frame proteins (ARFPs) are over-expressed in patients with HCV cirrhosis and hepatocellular carcinoma (HCC)

   • M. Schwartz
   • J. L. Walewski
   • A. D. Branch

   Abstracts Accepted for Plenary and Parallel Sessions Pages: S50 - S50

3. The polo-like kinase sak phosphorylates p53 and is haploinsufficient for hepatocellular carcinogenesis

   • M. A. Ko
   • J. Hudson
   • C. Swallow

   Abstracts Accepted for Plenary and Parallel Sessions Pages: S50 - S50

4. Estrogen receptor negative breast cancers express estrogen receptor mRNA

   • C. McMahon
   • A. Alkarain
   • J. Slingerland

   Abstracts Accepted for Plenary and Parallel Sessions Pages: S50 - S50

5. Outer breast quadrants demonstrate increased patterns of DNA genomic instability

   • D. L. Ellsworth
   • R. E. Ellsworth
   • C. Shriver

   Abstracts Accepted for Plenary and Parallel Sessions Pages: S50 - S51

6. A comparison of three tumor markers (MIA, TA90IC, S100B) in stage III melanoma patients

   • M. B. Faries
   • R. K. Gupta
   • D. L. Morton

   Abstracts Accepted for Plenary and Parallel Sessions Pages: S51 - S51

7. Cox-2 overexpression increases motility and invasion of breast cancer cells

   • A. Lucci
   • B. Singh
   • V. Ramakrishnan

   Abstracts Accepted for Plenary and Parallel Sessions Pages: S51 - S51

8. RNAi modulation of p12DOC-1 expression in human colorectal cancer

   • T. Sotsky-Kent
   • Z. Yuan
   • T. Weber

   Abstracts Accepted for Plenary and Parallel Sessions Pages: S51 - S51

9. The estrogen receptor (ER) as a novel target for therapeutics in breast cancer cell refractory to antihormone therapy

   • S. Lim
   • B. Amundsen
   • V. C. Jordan

   Abstracts Accepted for Plenary and Parallel Sessions Pages: S52 - S52

10. Randomized clinical trial of long-term outcome after curative resection of pancreatic head cancer by post-operative intra-arterial infusion chemotherapy

    • S. Nakamori
    • A. Miyamoto
    • M. Monden

    Abstracts Accepted for Plenary and Parallel Sessions Pages: S52 - S52

11. Treatment-related upper-limb morbidity one year after sentinel lymph node biopsy (SLNB) or axillary lymph node dissection (ALND) for stage I or II breast cancer

    • J. S. Rietman
    • P. U. Dijkstra
    • H. J. Hoekstra

    Abstracts Accepted for Plenary and Parallel Sessions Pages: S52 - S52

12. Proteomic serum analysis of differentially expressed proteins in early stage melanoma patients using SELDI-TOF mass spectrometry

    • L. Wilson
    • D. L. Morton
    • D. Hoon

    Abstracts Accepted for Plenary and Parallel Sessions Pages: S53 - S53

13. Resection of progressive or residual tumor after treatment with imatinib for advanced GI stromal tumors

    • P. Hohenberger
    • U. Schneider
    • P. Reichardt

    Abstracts Accepted for Plenary and Parallel Sessions Pages: S53 - S53

14. Clinical impact of FDG-PET on the management of esophageal cancer

    • C. P. Duong
    • H. Demitriou
    • R. J. Hicks

    Abstracts Accepted for Plenary and Parallel Sessions Pages: S53 - S54

15. Molecular profiling predicts colon cancer survival better than dukes staging

    • I. Yang
    • S. Eschrich
    • T. J. Yeatman

    Abstracts Accepted for Plenary and Parallel Sessions Pages: S54 - S54

16. Hyperthermic isolated limb perfusion with TNF and Melphalan for primarily irresectable soft tissue sarcoma; three time periods at risk for amputation

    • R. Van Ginkel
    • K. Thijssens
    • H. Hoekstra

    Abstracts Accepted for Plenary and Parallel Sessions Pages: S54 - S54

17. Effects of neoadjuvant chemoradiation on operative mortality and morbidity for pancreaticoduodenectomy

    • T. Y. Cheng
    • R. White
    • D. S. Tyler

    Abstracts Accepted for Plenary and Parallel Sessions Pages: S54 - S55

18. Complete response to neoadjuvant chemoradiation therapy for esophageal cancer does not confer a survival advantage

    • C. R. Schmidt
    • J. L. Tarpley
    • N. B. Merchant

    Abstracts Accepted for Plenary and Parallel Sessions Pages: S55 - S55

19. Intraperitoneal gemcitabine therapy for advanced adenocarcinoma of the pancreas

    • T. C. Gamblin
    • M. J. Egorin
    • D. L. Bartlett

    Abstracts Accepted for Plenary and Parallel Sessions Pages: S55 - S55

20. Intraductal papillary mucinous neoplasm of the pancreas: Importance of accurate histologic evaluation

    • C. P. Raut
    • K. R. Cleary
    • D. B. Evans

    Abstracts Accepted for Plenary and Parallel Sessions Pages: S55 - S55

21. In vivo expression of an adenoviral vector encoding soluble tie2 inhibits metastatic hepatic tumor growth

    • S. Sarraf-Yazdi
    • J. Mi
    • B. Clary

    Abstracts Accepted for Plenary and Parallel Sessions Pages: S56 - S56

22. Effecy of isolated hepatic perfusion (IHP) in patients with progressive unresectable colorectal cancer (CRC) liver metastases (LM) after irinotecan (CPT-11)

    • R. Alexander
    • S. Libutti
    • T. Beresneva

    Abstracts Accepted for Plenary and Parallel Sessions Pages: S56 - S56

23. Palliative Gastrectomy improves survival in metastatic gastric cancer

    • R. F. Saidi
    • N. N. Hanna
    • P. S. Dudrick

    Abstracts Accepted for Plenary and Parallel Sessions Pages: S56 - S56

24. Institutional Commitment to Rectal cancer screening results in earlier stage cancer on diagnosis

    • A. C. Battat
    • R. V. Rouse
    • S. M. Wren

    Abstracts Accepted for Plenary and Parallel Sessions Pages: S56 - S57

25. Breast cancer patients with pN0(i+) sentinel nodes are NOT node negative

    • T. Mehes
    • P. I. Tartler
    • S. Rosenbaum Smith

    Abstracts Accepted for Plenary and Parallel Sessions Pages: S57 - S57

26. Beyond the clinical trials: How prevalent are sentinel lymph node biopsies performed for breast cancer

    • M. A. Maggard
    • K. E. Lane
    • C. Y. Ko

    Abstracts Accepted for Plenary and Parallel Sessions Pages: S57 - S57

27. Breast cancer: Presentation and intervention in women with gastrointestinal metastasis and carcinomatosis

    • E. C. McLemore
    • B. A. Pockaj
    • J. H. Donohue

    Abstracts Accepted for Plenary and Parallel Sessions Pages: S57 - S58

28. Incidence and clinical significance of lymph node metastasis detected by imuno-histochemical stain in DCIS

    • M. B. El-Tamer
    • J. Chun
    • M. Mansukhani

    Abstracts Accepted for Plenary and Parallel Sessions Pages: S58 - S58

29. Axillary recurrence following sentinel node biopsy

    • J. S. Jeruss
    • D. J. Winchester
    • D. P. Winchester

    Abstracts Accepted for Plenary and Parallel Sessions Pages: S58 - S58

30. Ductal lavage (DL) findings in women with mammographic microcalcifications undergoing biopsy

    • S. A. Khan
    • J. A. Wolfman
    • M. Morrow

    Abstracts Accepted for Plenary and Parallel Sessions Pages: S58 - S59

31. High provider volume is associated with better outcomes for breast cancer surgery: analysis of 234,254 patients

    • U. Guller
    • S. Safford
    • N. Jain

    Abstracts Accepted for Plenary and Parallel Sessions Pages: S59 - S59

32. Proteomic analysis of BRCA-1 breast cancer, BRCA-1 carriers and sporadic breast cancer

    • S. Becker
    • L. Cazares
    • C. Laronga

    Abstracts Accepted for Plenary and Parallel Sessions Pages: S59 - S59

33. Isolated limb perfusion for unresectable melanoma of the limbs

    • E. M. Noorda
    • B. C. Vrouenraets
    • B. B. Kroon

    Abstracts Accepted for Plenary and Parallel Sessions Pages: S59 - S59

34. Specific active immunotherapy for primary melanoma: Experience with 5399 Patients

    • R. White
    • P. Mosca
    • H. F. Seigler

    Abstracts Accepted for Plenary and Parallel Sessions Pages: S59 - S60

35. Detection of melanoma lymph node metastases by proton magnetic resonance spectroscopy of fine-needle aspirates

    • J. Stretch
    • R. Somorjai
    • C. Lean

    Abstracts Accepted for Plenary and Parallel Sessions Pages: S60 - S60

36. Outcome in 846 cutaneous melanoma patients from a single center after negative sentinel node biopsy

    • V. S. Ka
    • J. F. Thompson
    • R. Uren

    Abstracts Accepted for Plenary and Parallel Sessions Pages: S60 - S60

37. Desmoplastic melanoma: A pathologically and clinically distinct form of cutaneous melanoma B

    • W. G. Hawkins
    • K. J. Busam
    • M. S. Brady

    Abstracts Accepted for Plenary and Parallel Sessions Pages: S61 - S61

38. Predictors and natural history of in-transit melanoma after sentinel lymphadenectomy

    • T. M. Pawlik
    • M. I. Ross
    • J. E. Gershenwald

    Abstracts Accepted for Plenary and Parallel Sessions Pages: S61 - S61

39. Multivariate prognostic model for patients with thick cutaneous melanoma: Results of a large multi-institutional study

    • S. C. Montgomery
    • K. S. Panageas
    • D. G. Cott

    Abstracts Accepted for Plenary and Parallel Sessions Pages: S61 - S62

40. Mitotic rate as a predictor for sentinel lymph node positivity in patients with thin melanomas

    • S. B. Kesmodel
    • G. C. Karakousis
    • F. R. Spitz

    Abstracts Accepted for Plenary and Parallel Sessions Pages: S62 - S62

41. Is parathyroid carcinoma a lethal disease

    • K. P. Kleinpeter
    • N. D. Perrier
    • J. F. Lovato

    Abstracts Accepted for Plenary and Parallel Sessions Pages: S62 - S62

42. AMES risk classification and extent of thyroidectomy for well-differentiated thyroid cancer in the united states

    • P. Haigh
    • D. Urbach
    • L. Rotstein

    Abstracts Accepted for Plenary and Parallel Sessions Pages: S62 - S62

43. Thyroid cancer: Is the incidence still increasing

    • N. Hodgson
    • B. Wohler-Torres
    • C. Solarzano

    Abstracts Accepted for Plenary and Parallel Sessions Pages: S62 - S63

44. Gland size is associated with changes in gene expression profiles in sporadic parathyroid adenomas

    • J. E. Rosen
    • N. G. Costouros
    • S. K. Libutti

    Abstracts Accepted for Plenary and Parallel Sessions Pages: S63 - S63

45. Clinical prognostic factors and outcomes for the surgical treatment of recurrent squamous cell carcinoma of the head and neck

    • V. M. Bondar
    • J. D. Ellenhorn
    • I. B. Paz

    Abstracts Accepted for Plenary and Parallel Sessions Pages: S63 - S63

46. Paranasal sinus and nasal fossae carcinoma. Prognostic factors

    • J. F. Carrillo
    • A. Guemes-Meza
    • L. F. Onate-Ocana

    Abstracts Accepted for Plenary and Parallel Sessions Pages: S63 - S63

47. Tissue eosinophilia: A valuable marker in assessing stromal invasion, locoregional recurrence & distant metastasis in head & neck squamous cell carcinomas

    • S. J. Alrawi
    • D. Tan
    • N. Rigual

    Abstracts Accepted for Plenary and Parallel Sessions Pages: S63 - S64

48. Electrical impedance scanning of thyroid nodules prior to thyroid surgery: A prospective study

    • A. Stojadinovic
    • S. I. Fields
    • A. Nissan

    Abstracts Accepted for Plenary and Parallel Sessions Pages: S64 - S64

49. Inhibition of HIF-1α reduces tumor growth and angiogenesis of human gastric cancer

    • O. Stoeltzing
    • M. F. McCarty
    • L. M. Ellis

    Abstracts Accepted for Plenary and Parallel Sessions Pages: S64 - S64

50. Emploving hepatoma hypoxia to augment herpes oncolytic therapy

    • R. H. Pin
    • M. Reinblatt
    • Y. Fong

    Abstracts Accepted for Plenary and Parallel Sessions Pages: S64 - S64